NaughtyPines

THE WEEK AHEAD: GDXJ, XOP, /CL

AMEX:GDXJ   VanEck Junior Gold Miners ETF
EARNINGS:

No earnings announcements this coming week in underlyings with highly liquid options with ideal rank/implied metrics (>70% rank/>50% 30-day implied).

EXCHANGE-TRADED FUNDS:

SLV (86/30)
GDX (80/17)
TLT (63/16
GDX (63/33)
GDXJ (61/36)
XOP (44/41)

Like a broken record for the umpteenth week in a row: precious metals,, with GDXJ offering the best volatility metrics (>50% rank/>35% 30-day implied) .

BROAD MARKET:

IWM (24/19)
SPY (20/15)
QQQ (16/19)
EEM (12/17)
EFA (16/12)

Objectively, broad market premium selling isn't paying greatly here in <90 days 'til expiry duration: IWM November 155 short straddle, 8.84, 5.7% of the current stock price; December 155 short straddle, 11.66, 7.5%; January 155 short straddle, 13.09, 8.4%, with the first expiry paying greater than 10% in March (March 20th 155, 16.47) with the correspondent March 20th nearest the 16 delta short strangle 130/175 paying 3.19. This isn't horrid, but represents a long time to wait for your candy, although a less than 50% max take profit on such a setup might be compelling for some. (e.g., 25% max take profit of .80 ($80) as opposed to waiting for a full 50.

FUTURES:

/SI (86/29)
/GC (80/16)
/UB (63/5)
/ZB (63/11)
/6B (62/26)
/ZS (65/26)
/ZN (49/6)
/ZC (43/23)
/CL (37/42)

Although /CL rank isn't ideal here, keep in mind that we had that mid-September OVX pop, which will skew where the current 30-day lies in relation to the 52-week range. The November 15th 58.5 short straddle is paying 6.67, 11.4% of where WTI is currently trading; the December 16th 58.5, 8.20, 14%, with their corresponding 16 delta short strangles paying 1.44* and 1.77** respectively, both of which beat a poke in the eye with a sharp stick.

VIX/VIX DERIVATIVES:

VIX finished the week at 15.32 ... . Continue to hand sit on short volatility setups, waiting for VIX prints of >20.

* -- The November 15th 51/70.
** -- The December 16th 49/71.5.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.